Clinical Trials Directory

Trials / Completed

CompletedNCT02988791

Evaluation of a Probiotic (Bifidobacterium in the Treatment of Infantile Colic (IC)

Randomized Clinical Trial to Evaluate the Efficacy of Bifidobacterium in the Treatment of Infantile Colic (IC)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
80 (actual)
Sponsor
Federico II University · Academic / Other
Sex
All
Age
1 Week – 7 Weeks
Healthy volunteers
Not accepted

Summary

Infantile colic (IC) criteria includes all of the following in subjects aged ≤ 4 months: paroxysms of irritability, fussing, or crying that start and stop without obvious cause; episodes lasting 3 or more hours per day and occurring at least 3 days per week for at least 1 week; and no failure to thrive. The condition is very common in the first 4 months of life (10-30 % of infants) with a peak prevalence at 6-8 weeks and is characterized by excessive and inconsolable crying without an identifiable cause. Infantile colic cause considerable stress for the baby and the family, huge medical expenses (the IC cause 10-20 % of all pediatric visits in the first 4 months of life) and frequent formula changes. The pathophysiology of IC is still poorly defined, but differences in gut microbiota composition seem to be involved. In particular, differences in the number and species of Lactobacilli spp, Klebsiella spp and Escherichia coli spp have been demonstrated in subjects with IC, and it has been postulated that these alterations could be responsible for an abnormal gas production within gut lumen resulting in distension and abdominal pain. These findings suggest the potential role of probiotics as preventive and therapeutic strategy for the IC.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTprobiotic (BIfidobacterium, BB-12®)probiotic (Bifidobacterium, BB-12®)
DIETARY_SUPPLEMENTPlaceboPlacebo

Timeline

Start date
2016-11-01
Primary completion
2017-09-01
Completion
2018-05-01
First posted
2016-12-09
Last updated
2019-04-16

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT02988791. Inclusion in this directory is not an endorsement.